Any feedback?
Literature summary for 3.4.24.79 extracted from
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A (2008), Hum. Reprod., 23, 1968-1975.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | a prospective screening study for trisomy 21 in singleton pregnancies is carried out by a combination of maternal age, fetal nuchal translucency, free beta-hCG and PAPP-A in a one-stop-clinic for first-trimester assessment of risk at 11-13 weeks of gestation. All three trisomies (13,18 and 21) are associated with increased maternal age, increased fetal nuchal translucency and decreased maternal serum PAPP-A | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| PAPP-A | - |
Homo sapiens |
| pregnancy-associated plasma protein-A | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
